Authors
Loading...
Indoxyl sulfate may be a therapeutic target for renal dysfunction-induced AF; hypothesis-generating and requires clinical validation.
Key points are not available for this paper at this time.
Aoki et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: